Searched for
TAKEDA PHARMA
Japan's Topix posts record-high close despite US tariffs on pharmaJapan's broad Topix index closed at an all-time high on Friday, despite pressure from pharmaceutical shares following new tariffs on the se...- Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talentThe Innovation Capability Centre plans to hire 750 professionals, including software engineers, data scientists, and cybersecurity experts,...
- Japanese pharma Takeda launches innovation centre, eyes to onboard AI-driven talentTakeda opens its first Innovation Capability Centre in Bengaluru, targeting to hire 750 professionals in AI, data science, and cybersecurit...
- Lupin signs patent licence pact with Takeda for novel gastrointestinal drug in Indian marketLupin Ltd has signed a non-exclusive patent licence agreement with Takeda Pharmaceutical to commercialise Vonoprazan tablets in India. The ...
- Sun Pharma, Cipla enter licensing agreement with Takeda to market novel gastrointestinal drug in IndiaSun Pharma and Cipla have entered a licensing deal with Takeda Pharmaceutical to commercialize Vonoprazan tablets in India. This novel drug...
- Sun Pharma inks pact with Takeda to introduce gastrointestinal drug in IndiaSun Pharmaceutical Industries announced a licensing deal with Takeda Pharmaceutical to market Vonoprazan, a novel gastrointestinal drug, in...
- Gland Pharma launches generic cancer treatment drug in USThe Hyderabad-based company said its product is therapeutically equivalent to Takeda Pharmaceuticals' Velcade for Injection.
- Takeda in talks to bring its dengue shot to IndiaIndia is not a part of the global Phase-3 trial of the Takeda dengue vaccine candidate, which means as per local regulation it will have to...
- Chief of Asia's largest pharmaceutical company urges transparency in virus vaccine rolloutTakeda, one of the world's biggest pharmaceutical companies, is not developing its own vaccine but has contracts with several firms to dist...
- Rashmi Barbhaiya, co-founder of Advinus Therapeutics resigns from the post of managing directorRashmi Barbhaiya, who co-founded Tata group-promoted pharmaceutical research company Advinus Therapeutics, has stepped down from the post o...
- Wipro rallies over 3% on Rs 2,400 cr order win from Takeda PharmaWipro rallied 3%, after it won an over Rs 2,400 cr deal from Takeda Pharma under which the former will support IT requirements of the pharm...
- Wipro bags Rs 2,400 crore Takeda Pharma dealWipro will be primary provider of IT infra mgmt services covering Takeda's entities across the world, touching 30,000 users in 16 different...
- Sun Pharmaceuticals files ANDAs for 4 products in Q1 FY14Sun Pharmaceutical Industries filed Abbreviated New Drug Applications for 4 products & received 9 approvals from USFDA in Q1 this fiscal.
- Pfizer reaches $2 billion Protonix settlement with Teva and Sun PharmaJapan's Takeda Pharmaceutical Co Ltd, Pfizer's partner, will receive 36 per cent or about $774 million from the settlement.
- Sun Pharma arm to buy Takeda's US-based generics subsidiary URL PharmaSun Pharmaceutical Industries today said its arm Caraco Pharma will buy Japanese drug maker Takeda Pharmaceuticals' US-based generics subsi...
- Tata group's Advinus Pharma ties up with Takeda Pharma for drug R&DAdvinus Pharma has entered into a joint drug discovery deal with Takeda Pharma, indicating interest of MNCs in Indian drug research.
- Japan's Takeda eyes Lupin, Cipla pharma business; shares surge in morning tradeShares of drug firms Cipla and Lupin surged after news reports surfaced that Takeda Pharmaceutical Co, is in talks to buy either of their p...
- Cipla, Lupin shares surge in morning trade on boursesShares of drug firms Cipla and Lupin surged after news reports surfaced that Takeda Pharmaceutical Co, is in talks to buy either of their p...
- Japan's Takeda eyes Lupin, Cipla pharma businessTakeda, Japan's largest pharmaceutical firm, has begun talks with two of India's biggest companies for purchasing either of their pharma bu...
- Astellas aims to emerge top player in transplantationJapan’s second-largest pharma company, the $10-billion Astellas Pharma, intends to emerge as a niche player in India.
Load More
